Israeli generic drug maker Teva reaches an agreement in principle to pay $4.25 billion over 13 years to settle a series of court cases over its role in the US opioid epidemichttps://t.co/EyPG5b0dwR
— AFP News Agency (@AFP) July 27, 2022
Source: Twitter
Discover more from #News247WorldPress
Subscribe to get the latest posts sent to your email.

